Human CAVIN4/cavin-4/MURC ORF/cDNA clone-Lentivirus plasmid (NM_001018116.2)
Cat. No.: pGMLV001664
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CAVIN4/cavin-4/MURC Lentiviral expression plasmid for CAVIN4 lentivirus packaging, CAVIN4 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
CAVIN4/cavin-4 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLV001664 |
Gene Name | CAVIN4 |
Accession Number | NM_001018116.2 |
Gene ID | 347273 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 1095 bp |
Gene Alias | cavin-4,MURC |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Blasticidin (BSD) |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGAACATAATGGGTCTGCTTCAAATGCTGATAAAATCCACCAGAATCGCCTGTCGAGTGTTACAGAAGATGAAGACCAAGACGCTGCTCTTACCATTGTGACTGTGCTGGACAAAGTAGCCTCCATCGTGGACAGTGTGCAGGCAAGCCAGAAGAGAATAGAAGAGAGACACAGGGAAATGGAAAATGCCATAAAATCCGTCCAGATTGACCTGTTGAAGCTTTCACAGTCGCATAGCAATACAGGGCATATCATTAACAAATTGTTTGAGAAAACCCGAAAAGTTAGTGCTCACATTAAAGATGTGAAAGCCCGGGTGGAGAAGCAACAAATTCATGTTAAAAAAGTTGAAGTCAAGCAAGAGGAAATAATGAAGAAAAACAAATTCCGCGTGGTAATATTCCAGGAGAAGTTTCGGTGTCCGACATCCCTGTCTGTTGTTAAAGACAGAAACCTAACTGAGAACCAAGAAGAGGATGATGATGATATCTTTGATCCCCCAGTAGATCTGTCTTCGGATGAAGAATATTATGTTGAAGAAAGCAGATCTGCCAGGCTTAGGAAGTCAGGCAAGGAGCACATTGATAATATCAAGAAGGCATTTTCCAAAGAAAACATGCAGAAGACACGGCAGAATCTTGACAAGAAAGTGAACAGAATTAGAACTAGAATAGTGACCCCGGAGAGGAGAGAGAGGCTAAGGCAGTCAGGAGAGAGGCTGAGACAGTCAGGGGAGAGGCTGAGACAGTCAGGGGAGAGGTTTAAGAAATCTATTTCTAATGCAGCTCCCTCAAAGGAAGCTTTTAAGATGCGCAGCCTCAGGAAAGGTAAGGACCGAACAGTGGCTGAAGGTGAGGAATGTGCCAGGGAGATGGGTGTGGACATCATTGCCAGGAGCGAGTCTCTGGGCCCCATCAGTGAGCTCTACTCTGATGAGCTCAGTGAACCAGAACACGAGGCAGCCAGGCCGGTGTATCCTCCCCATGAAGGAAGGGAAATCCCCACCCCCGAGCCTTTAAAAGTTACTTTTAAATCTCAGGTGAAAGTAGAGGATGATGAATCTCTTTTGTTAGATTTAAAGCACTCATCGTAA |
ORF Protein Sequence | MEHNGSASNADKIHQNRLSSVTEDEDQDAALTIVTVLDKVASIVDSVQASQKRIEERHREMENAIKSVQIDLLKLSQSHSNTGHIINKLFEKTRKVSAHIKDVKARVEKQQIHVKKVEVKQEEIMKKNKFRVVIFQEKFRCPTSLSVVKDRNLTENQEEDDDDIFDPPVDLSSDEEYYVEESRSARLRKSGKEHIDNIKKAFSKENMQKTRQNLDKKVNRIRTRIVTPERRERLRQSGERLRQSGERLRQSGERFKKSISNAAPSKEAFKMRSLRKGKDRTVAEGEECAREMGVDIIARSESLGPISELYSDELSEPEHEAARPVYPPHEGREIPTPEPLKVTFKSQVKVEDDESLLLDLKHSS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-MP2035-Ab | Anti-CAVN4/ CAVIN4/ MURC monoclonal antibody |
Target Antigen | GM-Tg-g-MP2035-Ag | CAVIN4 VLP (virus-like particle) |
ORF Viral Vector | pGMLV001664 | Human CAVIN4 Lentivirus plasmid |
ORF Viral Vector | pGMPC000192 | Human CAVIN4 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | vGMLV001664 | Human CAVIN4 Lentivirus particle |
Target information
Target ID | GM-MP2035 |
Target Name | CAVIN4 |
Gene ID | 347273, 68016, 714379, 313225, 101086012, 481632, 528386, 100054653 |
Gene Symbol and Synonyms | 2310039E09Rik,cavin-4,CAVIN4,MURC,RGD1310395 |
Uniprot Accession | Q5BKX8 |
Uniprot Entry Name | CAVN4_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Not Available |
Disease | Not Available |
Gene Ensembl | ENSG00000170681 |
Target Classification | Not Available |
This gene encodes a protein containing two coiled-coil regions. The encoded protein promotes Rho/ROCK (Rho-kinase) signaling in cardiac muscles cells, and may facilitate myofibrillar organization. [provided by RefSeq, Jun 2013]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.